Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Merck & Co. selects lead from new series of phosphodiesterase 10A inhibitors

April 18, 2012

PRINT nanofabrication allows precision synthesis of therapeutic particles

April 18, 2012

New Exp1 inhibitors show promise in a number of in vitro and in vivo cancer studies

April 18, 2012

New potential pancreatic cancer biomarker identified at H. Lee Moffitt Center

April 17, 2012

Scientists describe analgesic effects of novel cannabinoid CB2 receptor agonists

April 17, 2012

Regeneron Pharmaceuticals generates new anticancer antibody

April 17, 2012

Two new promising oncology programs presented

April 17, 2012

Multitargeted antimitotic drug achieves tumor regression in vivo

April 17, 2012

Preclinical data support clinical testing of AVEO antibody

April 17, 2012

Novel Astellas histone deacetylase inhibitor has encouraging pharmacokinetics

April 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.